NEA AI refers to the artificial intelligence investment activities and portfolio of New Enterprise Associates (NEA), one of the largest American venture capital firms. With over $25 billion in committed capital, NEA has invested in numerous AI-related companies across technology and healthcare sectors, supporting innovations in artificial intelligence, machine learning, and related fields. The firm's AI strategy spans early-stage startups to growth-stage companies, aiming to capitalize on advances in generative AI, large language models, and deep learning.
NEA's AI investments are part of its broader technology and healthcare focus, which has produced over 650 liquidity events, including more than 250 IPOs and 300 acquisitions. The firm's portfolio includes companies such as Databricks, a data and AI platform, and various healthcare AI ventures. NEA AI reflects the firm's long-standing commitment to backing transformative technologies, from its early investment in 3Com in 1981 to contemporary AI-driven enterprises.
History and Evolution
NEA was founded in 1977 by C. Richard (Dick) Kramlich, Charles (Chuck) Newhall III, and Frank Bonsal, Jr., with offices on both the East Coast and West Coast. The firm's early investments included 3Com, backed in 1981. Over the decades, NEA grew its funds from $16 million in the first fund to $3.3 billion in the sixteenth fund by 2017, often setting records for the largest venture capital funds. The firm's AI focus emerged as part of its technology investments, particularly in the 2010s and 2020s, as AI became a central theme in venture capital.
In 2025, NEA's investments included Databricks, a company known for its AI and data infrastructure, alongside healthcare firms like Acadia Pharmaceuticals and Amicus Therapeutics. The firm has also backed AI startups in areas such as natural language processing and computer vision, though specific details of its AI-only portfolio are not publicly disclosed.
Investment Strategy
NEA AI employs a multi-stage investment approach, providing capital from seed rounds to growth equity. The firm leverages its deep industry expertise to identify AI companies with potential for significant impact. NEA's strategy often involves investing in AI applications within healthcare, such as drug discovery and diagnostics, as well as in enterprise AI, including data platforms and ML tools. The firm also supports foundational AI research, backing companies that develop neural networks and transformer architectures.
NEA's AI investments are guided by its operational partners and venture partners, including former GE CEO Jeff Immelt, who joined in 2018. The firm's global presence, with offices in Menlo Park, London, New York, and affiliates in India and China, allows it to source AI deals worldwide. NEA typically leads or co-leads funding rounds, providing not only capital but also strategic guidance to portfolio companies.
Notable AI Portfolio Companies
Among NEA's AI-related investments, Databricks stands out as a leading provider of data and AI solutions, offering a unified platform for data science and machine learning. Other notable companies include healthcare AI firms like Commure, which focuses on healthcare technology, and Omniscient, which applies AI to various industries. NEA has also invested in AI infrastructure startups, such as those developing GPU-optimized software and cloud computing services.
While NEA does not exclusively focus on AI, its portfolio reflects a strong commitment to the sector. The firm's investments in companies like Figure AI, which develops humanoid robots, and Sanctuary AI, which works on general-purpose robots, highlight its interest in robotics and embodied AI. Additionally, NEA has backed AI-driven healthcare companies like Intuitive Surgical, known for its robotic surgery systems, though these may predate the formal "NEA AI" label.
Impact and Future Outlook
NEA AI has contributed to the growth of the AI ecosystem by providing early-stage funding to companies that later become major players. The firm's track record of successful exits, including IPOs and acquisitions, demonstrates its ability to identify and nurture AI innovations. As AI continues to evolve, NEA is likely to increase its investments in areas like generative AI, large language models, and AI safety, aligning with industry trends.
NEA's scale, with over $25 billion in committed capital, positions it to make substantial bets on AI. The firm's history of raising record-breaking funds, such as the $3.3 billion sixteenth fund, provides ample resources for AI investments. Looking ahead, NEA AI may expand into emerging fields like quantum computing and edge AI, though these remain speculative as of 2025.
See Also
- Flagship Pioneering - a life sciences venture capital firm with AI interests.
- Artificial intelligence - the broader field of AI technology.